Expression of CARD6, an NF-κB activator, in gastric, colorectal and oesophageal cancers

Pathology

Volumn 42, Issue 1, 2010, Pages 50-53

  Kim, Sung Soo ^a   Ahn, Chang Hyeok ^a   Kang, Mi Ran ^a   Kim, Yoo Ri ^a   Kim, Ho Shik ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

CARD6; Colorectal cancer; Expression; Gastric cancer; Oesophageal cancer

Indexed keywords

EID: 73649119192     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313020903434421     Document Type: Article

References (17)

1. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000; 39: 1415-1430
2. Dufner A, Pownall S, Mak TW. Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation. Proc Natl Acad Sci USA 2006; 103: 988-993
3. Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC. CARD6 is a modulator of NF-kappa B activation by Nod1-and Cardiak-mediated pathways. J Biol Chem 2003; 278: 31941-31949
4. Stehlik C, Dorfleutner A. COPs and POPs: Modulators of inflammasome activity. J Immunol 2007; 179: 7993-7998
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
6. Aggarwal BB. Nuclear factor-kB: The enemy within. Cancer Cell 2004; 6: 203-208
7. Perkins ND, Gilmore TD. Good cop, bad cop: The different faces of NF-kappaB. Cell Death Differ 2006; 13: 759-772
8. Tian F, Zang WD, Hou WH, Liu HT, Xue LX. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 318-326
9. Lee BL, Lee HS, Jung J, et al. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 2005; 11: 2518-2525
10. Dejardin E, Deregowski V, Chapelier M, et al. Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 1999; 18: 2567-2577
11. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-847
12. Kim SY, Oh YL, Kim KM, et al. Decreased expression of Baxinteracting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers. Pathology 2008; 40: 553-557
13. Panani AD. Cytogenetic and molecular aspects of gastric cancer: Clinical implications. Cancer Lett 2008; 266: 99-115.
14. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7: 61-77.
15. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117: 60-69
16. Keats JJ, Fonseca R, Chesi M, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131-144
17. Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: Implications for human disease. Oncogene 2006; 25: 6831-6843